dotMD.com
✓ Translated by DotMD AI Clinical Council Source: International journal of surgery (London, England) • Phase III Randomized Trial
Verify Primary Source: NIH PubMed PMID #37042316
Plain-English Research Story • 8th-Grade Reading Level

New Insights on Comparison of real-world benefits and safety evaluation of vacuum-assisted Elite: What a 1,470-Participant Study Found

In general, the 10-G VAB procedure is a reasonable alternative to the 14-G CNB procedure with higher accuracy.

Original Paper Title: “The comparison of efficacy and safety evaluation of vacuum-assisted Elite 10-G system and the traditional BARD 14-G core needle in breast diagnosis: an open-label, parallel, randomized controlled trial” (International journal of surgery (London, England), 2023-05-01)

Elena Rostova (AI Quant) Rigor Score
90 / 100
Sample Size (Participants)
N = 1,470
Evidence Classification
Phase III Randomized Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • The Bottom-Line Finding: In general, the 10-G VAB procedure is a reasonable alternative to the 14-G CNB procedure with higher accuracy.
  • Who Was Studied: Phase III Randomized Trial published in International journal of surgery (London, England) following 1,470 real-world participants.
  • Strength of the Evidence: Earned a 90/100 Study Rigor Score based on trial design, sample size, and peer-reviewed controls.
  • Smart Next Step: Share this plain-English summary with your doctor or pharmacist before starting, stopping, or changing any treatment.
The Full Story in Plain English

What the Study Found (In Plain English)

Why This Matters to You

Vacuum-assisted biopsy (VAB) and core needle biopsy (CNB) are both widely used methods in diagnosing breast lesions. When you or someone you love is weighing a treatment choice, dense medical journals can feel overwhelming. Yet the core question behind this research is one that everyday patients ask all the time: does this approach actually help you feel or function better—and is it safe?

How the Study Worked

To find out, researchers writing in International journal of surgery (London, England) conducted a phase iii randomized trial evaluating 1,470 real-world participants. Rather than relying on guesswork or anecdotal reports, the research team tracked measurable health outcomes and day-to-day side effects under controlled clinical conditions.

What the Study Found in Plain English

In general, the 10-G VAB procedure is a reasonable alternative to the 14-G CNB procedure with higher accuracy. We recommend the use of VAB for lesions with accompanying calcification or heterogeneous echo on US. Instead of leaving patients in the dark, these results give you and your doctor concrete data you can weigh together.

The Catch: What to Keep in Mind

Even strong medical studies have limits. Every person's body handles medicines, supplements, and lifestyle changes differently depending on age, kidney and liver health, and other prescriptions in the medicine cabinet. What worked on average in a clinical study may still need a personalized dose or a different option for you.

Bottom Line: Your Next Step

Bring this summary to your next doctor or pharmacist visit. Ask: "Based on my health history and current medications, does this research apply to me?" You can also click the formal study link below to inspect the original peer-reviewed paper directly.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Published in International journal of surgery (London, England) (2023-05-01) • Study Design: Phase III Randomized Trial • Participants: N = 1,470 • Biostatistical Rigor Score: 90/100. Primary Takeaway: In general, the 10-G VAB procedure is a reasonable alternative to the 14-G CNB procedure with higher accuracy.

Study Limitations & Caveats Before You Act

While this phase iii randomized trial scored 90/100 for research quality, clinical trials follow strict rules that may not match every patient's daily life. Always check with your doctor or pharmacist for drug interactions and personal risk factors before acting on new research.

Formal Peer-Reviewed Study Reference
“The comparison of efficacy and safety evaluation of vacuum-assisted Elite 10-G system and the traditional BARD 14-G core needle in breast diagnosis: an open-label, parallel, randomized controlled trial”
Published in International journal of surgery (London, England) (2023-05-01) • PMID/ID: 37042316
Read Formal Study

Related DotMD Clinical Hubs & Price Ledgers

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 37042316: New Insights on Comparison of real-world benefits and safety evaluation of vacuum-assisted Elite: What a 1,470-Participant Study Found

3 of 3 Free Questions Remaining